Pneumology - Original Articles Open access

Usefulness of CURB-65, pneumonia severity index and MuLBSTA in predicting COVID-19 mortality

Authors

Published
22 February 2022
Section
Pneumology - Original Articles

Abstract

The aim of our study is to evaluate the accuracy of CURB-65 and Pneumonia Severity Index (PSI), the most widely used scores for community acquired pneumonia, and MuLBSTA, a viral pneumonia score, in predicting 28-day mortality in Coronavirus Disease 2019 (COVID-19) pneumonia.We retrospectively collected clinical data of consecutive patients with laboratory-confirmed COVID-19 pneumonia admitted at Papa Giovanni XXIII Hospital from February 23rd to March 14th, 2020. We calculated at Emergency Department (ED) presentation CURB-65, PSI and MuLBSTA and we compared their performances in discriminating between survivors and non-survivors at 28 days. Among 431 hospitalized patients, the majority presented with hypoxic respiratory failure: median (interquartile range, IQR) PaO2/FiO2 ratio at admission was 228.6 (142.0-278.1). In the first 24 hours, 111 (27%) patients were administered low-flow oxygen cannula, 50 (12%) Venturi Mask, 95 (23%) non-rebreather mask, 106 (26%) non-invasive ventilation, 12 (3%) mechanical ventilation and 41 (9%) were not administered oxygen therapy. Mortality rate at 28-day was 35% (150/431). Between survivors and non-survivors, median (IQR) scores were, respectively, 1.0 (1.0-2.0) and 2.0 (2.0-3.0) for CURB-65 (p<0.001); 90.5 (76.0-105.5) and 115.0 (100.0-129.0) for PSI (p<0.001); 7.0 (5.0-10.0) and 11.0 (9.0-13.0) for MuLBSTA (p<0.001). Areas under the receiver operating characteristic curve (AUCs) for each score were, respectively, 0.725 (0.662-0.787), 0.776 (0.693-0.859) and 0.743 (0.680-0.806) (p>0,05). PSI and MuLBSTA did not show a better performance when compared to CURB-65. Although CURB-65, PSI and MuLBSTA scores are useful tools to discriminate between survivors and non-survivors in COVID-19 pneumonia, their diagnostic accuracy in discriminating 28-day mortality in COVID-19 pneumonia is moderate, as confirmed by AUCs <0.80, and there is a potential underestimation of disease severity in the low-risk classes. For this reason, they should not be recommended in ED to decide between inpatient and outpatient management in patients affected by COVID-19 pneumonia.

References

  1. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845. DOI: https://doi.org/10.2307/2531595
  2. Estella A. Usefulness of CURB-65 and pneumonia severity index for influenza A H1N1v pneumonia. Monaldi Arch Chest Dis 2012;77:118-21. DOI: https://doi.org/10.4081/monaldi.2012.144
  3. Kim MA, Park JS, Lee CW, Choi W Il. Pneumonia severity index in viral community acquired pneumonia in adults. PLoS One 2019;14:1-12. DOI: https://doi.org/10.1371/journal.pone.0210102
  4. Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Front Microbiol 2019;10:2752. DOI: https://doi.org/10.3389/fmicb.2019.02752
  5. Bradley P, Frost F, Tharmaratnam K, Wootton DG. Utility of established prognostic scores in COVID-19 hospital admissions: Multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res 2020;7:1-9. DOI: https://doi.org/10.1136/bmjresp-2020-000729
  6. Nguyen Y, Corre F, Honsel V, et al. Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect 2020;81:e96-e98. DOI: https://doi.org/10.1016/j.jinf.2020.05.049
  7. Novelli L, Raimondi F, Ghirardi A, et al. At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy. Panminerva Med 2021;63:51-61. DOI: https://doi.org/10.23736/S0031-0808.20.04063-X
  8. Ji D, Zhang D, Xu J, et al. Prediction for progression risk in patients with COVID-19 pneumonia: The CALL score. Clin Infect Dis 2020;71:1393-9. DOI: https://doi.org/10.1093/cid/ciaa414
  9. Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Development and validation of the 4C mortality score. BMJ 2020;370:1-13. DOI: https://doi.org/10.1136/bmj.m3339
  10. Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: A prognostic tool for early clinical decompensation. Ann Emerg Med 2020;76:442-53. DOI: https://doi.org/10.1016/j.annemergmed.2020.07.022

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.